Cardiogen vs Thymalin

Overview

Cardiogen and Thymalin are both studied in the peptide research space.

Cardiogen: A synthetic tripeptide (Ala-Glu-Asp) developed by Russian scientist Vladimir Khavinson for cardiac tissue support.

Thymalin: A thymic peptide complex developed in Russia and used clinically in the former Soviet Union for immunomodulation.

Evidence Comparison

Aspect	Cardiogen	Thymalin
Evidence Level	Low	Moderate
Human Studies	2	8
Preclinical Studies	8	22
Total Sources	12	30

Key Differences

Aspect	Cardiogen	Thymalin
Category	Other	Immune
Evidence Strength	Low	Moderate
Total Sources	12	30
Human Studies	2	8

Summary

• Cardiogen: Low evidence with 12 total sources (2 human)
• Thymalin: Moderate evidence with 30 total sources (8 human)

---

This comparison is for educational purposes only and is not medical advice. Consult a healthcare professional before making any decisions about peptide use.